Cellyan Biotechnology Stock (NASDAQ:HKPD)
Previous Close
$0.83
52W Range
$0.68 - $2.76
50D Avg
$0.87
200D Avg
$1.17
Market Cap
$9.12M
Avg Vol (3M)
$117.56K
Beta
3.61
Div Yield
-
HKPD Company Profile
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
HKPD Performance
Peer Comparison
| Ticker | Company |
|---|---|
| ATXG | Addentax Group Corp. |
| TLIH | Ten-League International Holdings Limited Ordinary Shares |
| LSH | Lakeside Holding Limited |
| JYD | Jayud Global Logistics Limited |
| PSIG | PS International Group Ltd. |
| NCEW | New Century Logistics (BVI) Limited |
| ARTW | Art's-Way Manufacturing Co., Inc. |
| CRGO | Freightos Limited Ordinary shares |
| VRME | VerifyMe, Inc. |